Companies in #Cell therapy
Found 3 companies operating in this sector.
Kyverna Therapeutics is a clinical-stage biopharmaceutical company developing autologous and allogeneic CAR T-cell therapies for autoimmune diseases. Kyverna is poised to become the first company to file a regulatory application for a CAR T-cell therapy in autoimmune disease.
Repligen is a bioprocessing-focused life sciences company developing and commercializing highly innovative bioprocessing technologies that are flexible, scalable, and cost-effective. Recently struck a $1.5 billion deal to acquire BioLife Solutions to expand its cell therapy product portfolio.
Biomanufacturing CDMO improving access to complex medicines through end-to-end biologics manufacturing, cell therapy and drug product fill-finish; investing $750M with Eli Lilly to expand US KwikPen device capacity.